Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aphria
AddedFeb 20, 2024
UpdatedJun 28, 2026
Aphria

Aphria

Acquired

Leading Canadian cannabis producer offering medical marijuana and cannabis oil. Operating in Canada.

HQ
Leamington, Ontario, CA
Founded
2014
Overview
Compare
Fundraising
Employees

Aphria Inc., founded in 2014 by Cole Cacciavillani and John Cervini, is a leading Canadian cannabis producer headquartered in Leamington, Ontario. The company specializes in producing, supplying, and selling medical marijuana and cannabis oil. Aphria operates primarily in Canada, focusing on both medicinal and recreational cannabis markets.

Aphria has achieved significant milestones, including a revenue of 36.92 million Canadian dollars in 2018. The company is publicly traded on the TSX under the symbol APHA and is now a subsidiary of Tilray. Irwin D. Simon serves as the Chief Executive Officer, guiding Aphria's growth and market presence.

Aphria - Similar Companies

Aurora Cannabis logo

Aurora Cannabis

auroramj.com

Canopy Growth logo

Canopy Growth

canopygrowth.com

Tilray logo

Tilray

tilraymedical.ca

PharmaCann logo

PharmaCann

pharmacann.com

MedMen logo

MedMen

CuraleafHoldnc. logo

CuraleafHoldnc.

curaleaf.com

Marijuana Company of America logo

Marijuana Company of America

Aquarius Cannabis logo

Aquarius Cannabis

Medical Marijuana logo

Medical Marijuana

TerrAscend logo

TerrAscend

terrascend.com

Dogecoin Cash logo

Dogecoin Cash

cbds.com

Cresco Labs logo

Cresco Labs

crescolabs.com

AmeriCann logo

AmeriCann

americann.co

DNA Genetics logo

DNA Genetics

dnagenetics.com

Sunburn Cannabis logo

Sunburn Cannabis

Aphria - Quick Facts

Who are Aphria's competitors?

Companies similar to Aphria include Aurora Cannabis, Canopy Growth, Tilray and PharmaCann.

When was Aphria founded?

Aphria was founded in 2014.

Where is Aphria's headquarters located?

Aphria's headquarters is located in Leamington, Ontario, CA.

How much has Aphria raised to-date?

As of Jun 8, 2020, Aphria has raised a total of $648M (USD).

Aphria - Classification

Ownership
  • Public
Technology
  • Agriculture
Geographic Exposure
  • Canada
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Cannabis
Tags
  • Data
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 11 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325411Medicinal and Botanical Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 2833Medicinal Chemicals And Botanical Products
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 2830Drugs